価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-PD-L1, Rat-Mono(6C11-3A11)
データシート※最新のデータシートでない場合があります
FDV-0054 FNAフナコシ
フナコシ株式会社
100 μl ¥70,000 3個以上 追加

在庫・価格 : 2025年04月29日 23時55分 現在

Anti-PD-L1, Rat-Mono(6C11-3A11)

  • 商品コード:FDV-0054
  • メーカー:FNA
  • 包装:100μl
  • 価格: ¥70,000
  • 在庫:3個以上
使用文献
No. 文献情報 備考 参照
1 Sajiki Y et al. Prostaglandin E<sub>2</sub> Induction Suppresses the Th1 Immune Responses in Cattle with Johne&#39;s Disease. Infect Immun 2018 May;86(5)
Sajiki Y et al
2018/01/01
PubMed
2 Sajiki Y et al. Prostaglandin E<sub>2</sub>-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection. J Immunol 2019 Sep;203(5):1313-1324
Sajiki Y et al
2019/01/01
PubMed
3 Goto S et al. Upregulation of PD-L1 Expression by Prostaglandin E<sub>2</sub> and the Enhancement of IFN-&#x3B3; by Anti-PD-L1 Antibody Combined With a COX-2 Inhibitor in <i>Mycoplasma bovis</i> Infection. Front Vet Sci 2020;7:12
Goto S et al
2020/01/01
PubMed
4 Sajiki Y et al. Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression. Sci Rep 2021 Jan;11(1):1063
Sajiki Y et al
2021/01/01
PubMed
5 Takeuchi H et al. Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers. Front Vet Sci 2020;7:330
Takeuchi H et al
2020/01/01
PubMed
6 Maekawa N et al. PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma. NPJ Precis Oncol 2021 Feb;5(1):10
Maekawa N et al
2021/01/01
PubMed
7 Gulay KCM et al. Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages. Sci Rep 2022 Feb;12(1):2124
Gulay KCM et al
2022/01/01
PubMed
8 Owaki R et al. Regulation of programmed death ligand 1 expression by interferon-&#x3B3; and tumour necrosis factor-&#x3B1; in canine tumour cell lines. Vet Comp Oncol 2023 Jun;21(2):279-290
Owaki R et al
2023/01/01
PubMed
9 Ganbaatar O et al. Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade. Immun Inflamm Dis 2021 Dec;9(4):1573-1583
Ganbaatar O et al
2021/01/01
PubMed
10 Ganbaatar O et al. PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade. PLoS One 2020;15(11):e0234218
Ganbaatar O et al
2020/01/01
PubMed
11 Tiyamanee W et al. Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in sheep. Vet Immunol Immunopathol 2023 Jul;261:110609
Tiyamanee W et al
2023/01/01
PubMed
  • No.: 1
  • 文献情報:
    Sajiki Y et al. Prostaglandin E<sub>2</sub> Induction Suppresses the Th1 Immune Responses in Cattle with Johne&#39;s Disease. Infect Immun 2018 May;86(5)
    Sajiki Y et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sajiki Y et al. Prostaglandin E<sub>2</sub>-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection. J Immunol 2019 Sep;203(5):1313-1324
    Sajiki Y et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Goto S et al. Upregulation of PD-L1 Expression by Prostaglandin E<sub>2</sub> and the Enhancement of IFN-&#x3B3; by Anti-PD-L1 Antibody Combined With a COX-2 Inhibitor in <i>Mycoplasma bovis</i> Infection. Front Vet Sci 2020;7:12
    Goto S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Sajiki Y et al. Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression. Sci Rep 2021 Jan;11(1):1063
    Sajiki Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Takeuchi H et al. Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers. Front Vet Sci 2020;7:330
    Takeuchi H et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Maekawa N et al. PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma. NPJ Precis Oncol 2021 Feb;5(1):10
    Maekawa N et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Gulay KCM et al. Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages. Sci Rep 2022 Feb;12(1):2124
    Gulay KCM et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Owaki R et al. Regulation of programmed death ligand 1 expression by interferon-&#x3B3; and tumour necrosis factor-&#x3B1; in canine tumour cell lines. Vet Comp Oncol 2023 Jun;21(2):279-290
    Owaki R et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Ganbaatar O et al. Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade. Immun Inflamm Dis 2021 Dec;9(4):1573-1583
    Ganbaatar O et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Ganbaatar O et al. PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade. PLoS One 2020;15(11):e0234218
    Ganbaatar O et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Tiyamanee W et al. Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in sheep. Vet Immunol Immunopathol 2023 Jul;261:110609
    Tiyamanee W et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed